Minerva Surgical, Inc.
Minerva Surgical, Inc. (UTRS) Revenue
Annual & quarterly revenue history · segment & region breakdown
UTRS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMinerva Surgical, Inc. trailing twelve-month (TTM) revenue is $0.05B, a decrease of 3.47% year-over-year from $0.05B in FY2022.
Revenue trend
2022 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.05B | -$0.00B | -3.47% |
| 2021-12-31 | $0.05B | +$0.01B | +37.96% |
| 2020-12-31 | $0.04B | +$0.01B | +45.19% |
| 2019-12-31 | $0.03B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Minerva Surgical, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Minerva Surgical, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Minerva Surgical, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
UTRS revenue · 4 questionsUTRS's trailing twelve-month (TTM) revenue is $0.05B. That is a decrease of 3.47% year-over-year from $0.05B in FY2022.
▸ Source: FMP · Minerva Surgical, Inc. SEC filings · GAAP · Minerva Surgical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026